2409109-65-3

2409109-65-3 structure
2409109-65-3 structure
  • Name: JNK3 inhibitor-4
  • Chemical Name: JNK3 inhibitor-4
  • CAS Number: 2409109-65-3
  • Molecular Formula: C28H27N7O
  • Molecular Weight: 477.56
  • Catalog: Signaling Pathways MAPK/ERK Pathway JNK
  • Create Date: 2023-01-08 20:28:22
  • Modify Date: 2024-04-13 23:35:02
  • JNK3 inhibitor-4 is a potent inhibitor of JNK3 (IC50=1.0 nM) based on 2-aryl-1-pyrimidinyl-1H-imidazole-5-yl acetonitrile. JNK3 inhibitor-4 shows excellent selectivity over other protein kinases including isoforms JNK1 (IC50=143.9 nM) and JNK2 (IC50=298.2 nM)[1]. JNK3 inhibitor-4 has neuroprotective effect and predicated blood-brain barrier permeability[1].

Name JNK3 inhibitor-4
Description JNK3 inhibitor-4 is a potent inhibitor of JNK3 (IC50=1.0 nM) based on 2-aryl-1-pyrimidinyl-1H-imidazole-5-yl acetonitrile. JNK3 inhibitor-4 shows excellent selectivity over other protein kinases including isoforms JNK1 (IC50=143.9 nM) and JNK2 (IC50=298.2 nM)[1]. JNK3 inhibitor-4 has neuroprotective effect and predicated blood-brain barrier permeability[1].
Related Catalog
Target

JNK3:1.0 nM (IC50)

JNK1:143.9 nM (IC50)

JNK2:298.2 nM (IC50)

In Vitro JNK3 inhibitor-4 (化合物 15d) (1,5,10,20 μM; 24 h 或 48 h) 抑制 Aβ1-42 诱导的对大鼠原代皮层神经元的细胞毒性[1]。 JNK3 inhibitor-4 (10, 20 μM; 24 h、48 h) 抑制 10 μM Aβ1-42 或 0.5 μM Anisomycin (HY-18982) 诱导的大鼠皮层神经元 c-jun 磷酸化和 APP 磷酸化[1]。 JNK3 inhibitor-4 (50 μM; 4 h) 在 Caco-2 试验中具有高渗透性,根据 PAMPA 试验中的有效渗透系数 (Pe) > 4,预测其具有血脑屏障 (CNS+) 渗透性[1]。 JNK3 inhibitor-4 也抑制 GSK3α (h)、GSK3β (h)、JNK1、2、MKK6、MOK、SAPK2a (h)、SAPK2a (T106 M) (h)、SAPK2b (h)、MKK4、JNK1α1 (h) 和JNK2α1 (h),其 IC50 值分别为 5.78、11.7、15.1、1.18、3.10、1.19、0.280、0.970、0.860 和 0.340 μM[1]。 Western Blot Analysis[1] Cell Line: Primary rat cortex neuron Concentration: 10 μM and 20 μM Incubation Time: 24 hours Result: Monomeric Aβ1-42 induced c-jun phosphorylation dose-dependently and that was inhibited by JNK3 inhibitor-4 in concentration-dependent manner. Cell Viability Assay[1] Cell Line: Primary rat cortex neuron Concentration: 1, 5, 10, 20 μM Incubation Time: 24 hours and 48 hours Result: Showed neuroprotective effect and increased cell viability under Aβ1-42 treatment.
In Vivo JNK3 inhibitor-4 (化合物 15d) 能够改善阿尔茨海默病模型小鼠的记忆力。JNK3 inhibitor-4 (10 mg/kg 或 30 mg/kg; 静脉注射; 每周 3 次,共 1 个月) 在 Y 迷宫试验和被动回避试验中,与 APP/PS1 载药组相比,显著改善了小鼠的自发改变和反应延迟行为 (第 27 天或第 30 天),并表现出剂量相关性[1]。 JNK3 inhibitor-4 (30 mg/kg; 静脉注射; 单剂量; 记录 0-6 h) 在 SD 大鼠中显示血脑屏障通透性,脑/血浆浓度比为 0.02 (26 ng/g vs 1084 ng/mL)[1]。 Pharmacokinetics in rats[1] Route Dose (mg/kg) AUC0-t (ng·h/mL) Cmax (ng/mL) Tmax (h) T1/2 (h) BA (%) IV 1 718.0 0.22 PO 3 337.5 377.82 0.63 0.34 15.67
References

[1]. Jun J, et al. Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease. Eur J Med Chem. 2023 Jan 5;245(Pt 1):114894.  

Molecular Formula C28H27N7O
Molecular Weight 477.56
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.